<?xml version="1.0" encoding="UTF-8"?>
<results title="monoterpene">
 <result pre="and crude fiber, minerals (calcium, iron, sodium, potassium) 13 ." exact="Thymoquinone" post="(26.8-54.8%), p-cymene (14.7-38.0%), longifolene (1.2-10.2%), Î±-thujene (1.3-10.1%), carvacrol (0.5-4.2%),"/>
 <result pre="fixed oil, followed by oleic acid (25%), palmitic acid (18%)." exact="Thymoquinone" post="(2-isopropyl-5-methyl-1,4-benzoquinone) is present at concentration of 3.5-8.7 mg/g in"/>
 <result pre="products and 5-hydroxy-eicosa-tetra-enoic acid (5-HETE) from polymorphonuclear leukocytes 21 ." exact="Thymoquinone" post="has exhibited anti-histaminic, anti-inflammatory and immunoboosting effects 22 ."/>
 <result pre="cells and nitric oxide, eosinophils, macrophages and lymphocytes 30 ," exact="Thymoquinone" post="decreased leukotriene 31 , OVA IgE &amp;amp; IgG1, IL-4,"/>
 <result pre="and T. rubrum) 38 were the subject of some studies." exact="Thymoquinone" post="exhibited strong antimicrobial properties against Gram negative and positive"/>
 <result pre="while naltrindole had no effects on nociceptive response of thymoquinone." exact="Thymoquinone" post="and N. sativa seed fixed oil decreased the antinociceptive"/>
 <result pre="Darakhshan S. Bidmeshki Pour A. Hosseinzadeh Colagar A. Sisakhtnezhad S." exact="Thymoquinone" post="and its therapeutic potentials Pharmacological research. 95-96 2015 138"/>
 <result pre="University - Science. 21 2009 155 161 50 Abukhader M.M." exact="Thymoquinone" post="in the clinical treatment of cancer: Fact or fiction?"/>
</results>
